ÖZCAN, M. Et Al. 2019. Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.33, no.2 , 170-180.

ÖZCAN, M., CANPOLAT, S., BULMUŞ, Ö., ÜLKER, N., TEKTEMUR, A., TEKİN, S., ... ÖZCAN, S.(2019). Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.33, no.2, 170-180.

ÖZCAN, METE Et Al. "Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice," FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.33, no.2, 170-180, 2019

ÖZCAN, METE Et Al. "Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.33, no.2, pp.170-180, 2019

ÖZCAN, M. Et Al. (2019) . "Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.33, no.2, pp.170-180.

@article{article, author={METE ÖZCAN Et Al. }, title={Agomelatine pretreatment prevents development of hyperglycemia and hypoinsulinemia in streptozotocin-induced diabetes in mice}, journal={FUNDAMENTAL & CLINICAL PHARMACOLOGY}, year=2019, pages={170-180} }